Management of Mild-to-Moderate Hypertriglyceridemia
Risk Stratification and Initial Assessment
- For a person with triglycerides of 180 mg/dL and normal LDL, the American Heart Association recommends evaluating for secondary causes that commonly drive triglyceride elevation, such as uncontrolled diabetes or prediabetes, hypothyroidism, excessive alcohol intake, medications, renal disease, obesity, and metabolic syndrome 1, 2
- The American College of Cardiology suggests that a triglyceride level of 180 mg/dL falls into the mild-to-moderate hypertriglyceridemia range, which is associated with increased cardiovascular risk but not immediate pancreatitis risk 1
Lifestyle Interventions: The Foundation of Treatment
- The American Heart Association recommends dietary modifications as the most effective initial intervention for mild-to-moderate hypertriglyceridemia, including weight loss, restricting added sugars to <6% of total daily calories, limiting total fat to 30-35% of total daily calories, and eliminating or severely restricting alcohol consumption 1, 3
- The National Lipid Association suggests that increasing dietary omega-3 fatty acids through fatty fish consumption (2-3 servings weekly) can help lower triglyceride levels 3
- The American College of Sports Medicine recommends engaging in at least 150 minutes per week of moderate-intensity aerobic activity, or 75 minutes per week of vigorous-intensity activity, and adding resistance training with 8-10 different exercises, 1-2 sets per exercise, 10-15 repetitions at moderate intensity, 2 days per week 2
Pharmacological Therapy Considerations
- The American College of Cardiology recommends calculating the 10-year atherosclerotic cardiovascular disease (ASCVD) risk to determine if statin therapy is warranted for cardiovascular risk reduction, and considering statin therapy if the 10-year ASCVD risk is ≥7.5% (moderate-to-high risk) 1
- The American Diabetes Association suggests that statin therapy should be considered for individuals with diabetes, as this automatically places them in a higher risk category with an LDL goal <100 mg/dL 4, 5
- The National Lipid Association recommends against initiating fibrate therapy for mild hypertriglyceridemia with normal LDL, as this is not supported by guidelines and exposes patients to unnecessary medication risks 2, 3
Monitoring and Follow-Up
- The American Heart Association recommends reassessing fasting lipid panel in 6-12 weeks after implementing lifestyle modifications, and re-evaluating for undiagnosed or undertreated secondary causes if triglycerides remain >150 mg/dL despite adherence to lifestyle changes 1, 2
- The National Lipid Association suggests monitoring lipid levels annually, or every 2 years if all values remain optimal (LDL <100 mg/dL, HDL >50 mg/dL, triglycerides <150 mg/dL) 3, 5